Putnam Investments’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Putnam Investments’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-14,579	Closed	-$2.23M	–	911
2019 Q3	$2.23M	Sell	14,579 -9,934	-41%	-$1.63M	﹤0.01%	702
2019 Q2	$3.16M	Buy	24,513 +1,000	+4%	+$119K	0.01%	636
2019 Q1	$2.77M	Buy	23,513 +831	+4%	+$83.8K	0.01%	648
2018 Q4	$2.08M	Hold	22,682	–	–	0.01%	633
2018 Q3	$2.55M	Hold	22,682	–	–	0.01%	719
2018 Q2	$2.09M	Buy	22,682 +1,770	+8%	+$172K	﹤0.01%	711
2018 Q1	$2.09M	Buy	+20,912	New	+$2.25M	﹤0.01%	705

Other funds holding LKFT

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return

Putnam Investments's LKFT Position: Q4 2019 in Review

Putnam Investments sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2019, closing a stake of 14,579 shares — an estimated $2.23M sold.

Putnam Investments first reported a position in LKFT in Q1 2018 and held it in 7 quarters. The position peaked at $3.16M in Q2 2019. 137 funds tracked by Wall St. Rank hold LKFT as of Q4 2019.

Putnam Investments reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2019 after selling out during the quarter.
Putnam Investments sold 14,579 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2019, an estimated $2.23M.
Putnam Investments first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2018 and held it in 7 quarters.
Putnam Investments's Lakefront Biotherapeutics American Depositary Shares position peaked at $3.16M in Q2 2019.
137 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2019.

Based on Putnam Investments's 13F filing for Q4 2019, filed 14 Feb 2020.